[1] Ashkar S,Weber G F, Panoutsakopoulou V, et al. Eta-1(Osteopontin): An early component of type-1(cell-mediated) immunity. Science, 2000, 287:860-864.
[2] Civera M, Arosio D, Bonato F, et al. Investigating the interaction of cyclic RGD peptidomimetics with αVβ Integrin by biochemical and molecular docking studies. Cancers, 2017, 9:128.
[3] Iqbal J, Sarkar-Dutta M, Mcrae S, et al. Osteopontin regulates HCV replication and assembly via interaction with HCV proteins and lipid droplets and by binding to receptors, ανβ3 and CD44. J Virol.2018:JVI.02116-17.
[4] Zhang C, Liu H, Cui Y, et al. Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin ανβ3 for staging liver fibrosis in rat model.Int J Nanomedicine, 2016, 11:1097.
[5] Amin SA, Adhikari N, Bhargava S, et al. An integrated QSAR modeling approach to explore the structure–property and selectivity relationships of N -benzoyl- l -biphenylalanines as integrin antagonists. Mol Divers, 2018, 22:129-158.
[6] Huang G, Brigstock DR. Integrin expression and function in the response of primary culture hepatic stellate cells to connective tissue growth factor(CCN2). J Cell Mol Med, 2011, 15: 1087-1095.
[7] Gao R, Brigstock DR. Connective tissue growth factor(CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin v3 and heparan sulfate proteoglycan. J Biol Chem, 2004, 279: 8848-8855.
[8] Locatelli L, Cadamuro M, Spirlì C, et al. Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis. Hepatology, 2016, 63:965.
[9] Sugiyama A, Kanno K, Nishimichi N, et al. Periostin promotes hepatic fibrosis in mice by modulating hepatic stellate cell activation via alphav integrin interaction. J Gastroenterol, 2016, 51: 1161-1174.
[10] Martin K, Pritchett J, Llewellyn J, et al. PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofi-broblasts promote liver fibrosis.Nat Commun, 2016, 7:12502.
[11] Ines M, Till L, Nada C, et al. Alpha8 Integrin(Itga8) signalling attenuates chronic renal interstitial fibrosis by reducing fibroblast activation, not by interfering with regulation of cell turnover: Plos One,2016, 11:e0150471.
[12] Civitarese RA, Talior-Volodarsky I, Desjardins JF, et al. The α11 integrin mediates fibroblast-extracellular matrix-cardiomyocyte interactions in health and disease. Am J Physiol Heart Circ Physiol,2016, 311:ajpheart.00918.2015.
[13] Schuppan D, Ashfaq-Khan M, Ai TY, et al. Liver fibrosis: Direct antifibrotic agents and targeted therapies. Matrix Biol, 2018, 69:435-451.
[14] Zhou YQ, Lv XP, Li S, et al. Synergy of urokinase lltype plasminogen activator receptor isomer(D1D2) and integrin α5β1 causes malignant transformation of hepatic cells and the occurrence of liver cancer. Mol Med Rep, 2014, 10:2568-2574.
[15] Vassos N, Rau T, Merkel S, et al. Prognostic value of β1 integrin expression in colorectal liver metastases. Int J Clin Exp Pathol, 2014, 7:288-300.
[16] Kasdal MA, Manon-Jensen T, Genovese F, et al. Novel insights into the function and dynamics of extracellular matrix in liver fibrosis. Am J Physiol Gastrointest Liver Physiol,2015, 308:G807.
[17] Azzariti A, Mancarella S, Porcelli L, et al. Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin‐332/α3 integrin axis recovery of focal adhesion kinase ubiquitination. Hepatology, 2016, 64:2103-2117.
[18] Zhao Y, Bachelier R, Treilleux I, et al. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases. Cancer Res, 2007, 67:5821-5830.
[19] Jin Y, Chen JN, Feng ZY, et al.(2014) OPN and avβ3 expression are predictors of disease severity and worse prognosis in hepatocellular carcinoma.PLoS One, 2014, 9:e87930-e87930.
[20] Yan Q, Jiang L, Liu M, et al. ANGPTL1 interacts with integrin α1β1 to suppress HCC angiogenesis and metastasis by inhibiting JAK2/STAT3 signaling. Cancer Res, 2017:canres.0579. |
